Point-of-care Molecular Diagnostics Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 2040 2017 – 2025

Press Release

In 2019, the market size of Point-of-care Molecular Diagnostics Market is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2019 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Point-of-care Molecular Diagnostics .

This report studies the global market size of Point-of-care Molecular Diagnostics , especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

Request Sample Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=3639&source=atm

This study presents the Point-of-care Molecular Diagnostics Market production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Point-of-care Molecular Diagnostics history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global Point-of-care Molecular Diagnostics market, the following companies are covered:

Drivers and Restraints

The global market for point-of-care (PoC) molecular diagnostics is predicted to rise at a solid pace in the next couple of years because of the rise in instances of infectious diseases and also the increasing awareness in the public about the pre-disease detection. Quick unraveling of the causative agents is the key to treating such diseases successfully.

Apart from that, increasing research and development owing to rising funding by both government and private entities is also having a positive impact on the market. This has led to new and better products being rolled out every now and then. Thermo Fisher Scientific, for example, has launched the latest versions of oncomine BRCA research assay and oncomine comprehensive assay (OCA). This assay uses unique NGS workflow to identify all classes of BRCA1/2 alterations. Such developments are providing a solid impetus to the market for point-of-care diagnostics.

One factor posing a challenge to the market, on the other hand, is the protracted time needed for developing molecular diagnostics. This is because the development process consists of numerous stages involving prototype designing, research, testing, and pre- and post-marketing activities. Besides, complicated regulatory processes have also served to restrain the market.

Global Point-of-care Molecular Diagnostics Market: Market Potential

Going forward, it is felt that progress in DNA sequencing and analysis will further speed up accurate detection of the causative agents. These kinds of technological progress is expected to provide further impetus to the market for point-of-care diagnostics.

The point-of-care diagnostics at present finds usage in the domains of oncology, infectious diseases, and hematology and endocrinology. Of those, the infectious diseases are driving most of the demand in the market. This is mainly on account of rising cases of Zika and other viruses causing deadly maladies.

Global Point-of-care Molecular Diagnostics Market: Regional Analysis

From a geographical standpoint, uptake of point-of-care molecular diagnostics is maximum in North America owing to the increasing occurrence of both cancer and infectious diseases. Another factor that makes North America a market leader is the presence of many key players in the region – this has resulted in introduction of many POC molecular diagnostics products.

Global Point-of-care Molecular Diagnostics Market: Competitive Landscape 

A handful of well-entrenched large companies of the likes of Abbott, Roche, and Danaher hold a sway over the market. A few other notable players are BioMerieux, Bayer, Sysmex, and Bio-Rad Laboratories. However with new companies entering the fray, competition in the worldwide point-of-care molecular diagnostics market is set to heat up in the near future.

Savvy players are seen trying to bolster their positions in the market through research and development of better products and strategic acquisitions.

Request For Discount On This Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=3639&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Point-of-care Molecular Diagnostics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Point-of-care Molecular Diagnostics , with price, sales, revenue and global market share of Point-of-care Molecular Diagnostics in 2017 and 2019.

Chapter 3, the Point-of-care Molecular Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Point-of-care Molecular Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Customize This Report @ https://www.tmrresearch.com/sample/sample?flag=CR&rep_id=3639&source=atm

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Point-of-care Molecular Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Point-of-care Molecular Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

This post was originally published on Food and Beverage Herald

Related posts